GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $6.5B | +9.4% | 2.3% | 5.4% |
| Selling, general and administrative (TTM) | $6.5B |
|---|---|
| YoY | +9.4% |
| 5-year CAGR | 2.3% |
| 10-year CAGR | 5.4% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $5.8B | −5.2% |
| 2024 | $6.1B | 0.0% |
| 2023 | $6.1B | +7.4% |
| 2022 | $5.7B | +8.1% |
| 2021 | $5.2B | +1.8% |
| 2020 | $5.2B | +17.6% |
| 2019 | $4.4B | +8.0% |
| 2018 | $4.1B | +4.6% |
| 2017 | $3.9B | +14.1% |
| 2016 | $3.4B | −0.8% |
| 2015 | $3.4B | +14.9% |
| 2014 | $3.0B | +75.6% |
| 2013 | $1.7B | +16.3% |
| 2012 | $1.5B | +17.6% |
| 2011 | $1.2B | +18.9% |
| 2010 | $1.0B | +10.3% |
| 2009 | $947M | +18.7% |
| 2008 | $797M | +13.0% |
| 2007 | $706M | — |